Max Robotics — Global Service Robot Directory + US Certification

About

Kareem Rayn is a leading researcher in the field of prostate cancer imaging, with a primary focus on improving the preoperative staging and risk assessment of prostate cancer using multiparametric MRI (mpMRI). His most significant contribution is the development of a novel MRI grading system for the assessment of risk of extraprostatic extension (EPE), detailed in his highly cited 2019 paper (238 citations). This system provides a standardized, non-invasive method to predict the pathological extent of cancer beyond the prostate gland, directly aiding surgeons in planning nerve-sparing robotic prostatectomies and improving patient outcomes. Rayn’s work also explores the impact of neoadjuvant therapies, such as antiandrogen and androgen deprivation therapy, on mpMRI staging accuracy before robotic prostatectomy, as seen in his 2019 study (8 citations). By bridging radiology and urologic oncology, Rayn’s research enhances the precision of prostate cancer management, reducing unnecessary overtreatment while optimizing surgical strategies. His grading system has become a valuable tool in clinical practice, influencing how radiologists and urologists interpret MRI findings for localized prostate cancer.